Pantoprazole Sodium Delayed-Release Tablets

Pantoprazole Sodium Delayed-Release Tablets

Categories : Proton Pump Inhibitor

Product Packaging : 10 / 30 tablets

Product Composition : 40 mg

Send Message

Pantoprazole Sodium delayed-release tablets are proton pump inhibitor (PPI) formulations designed with enteric coating technology to protect the active ingredient from gastric acid degradation. This ensures targeted release in the intestine, providing consistent acid suppression and effective management of acid-related gastrointestinal disorders.

In international pharmaceutical markets, Pantoprazole sodium delayed release tablets exporter India and enteric coated PPI tablet supplier India are widely searched by distributors and bulk importers. Genliva Wellness LLP, Himatnagar, operates as a pharma exporter India delayed release gastro medicines partner, offering high-quality PPI formulations for global supply and contract manufacturing requirements.

Pantoprazole sodium delayed-release tablets are formulated to prevent degradation of the active ingredient in acidic gastric conditions, ensuring release in the intestine for optimal efficacy. The formulation provides sustained acid suppression and reliable therapeutic performance.

  • Proton pump inhibitor for effective reduction of gastric acid secretion
  • Delayed-release formulation for targeted intestinal drug delivery
  • Protects active ingredient from stomach acid degradation
  • Provides prolonged and consistent acid control
  • Suitable for once-daily dosing in most cases
  • Manufactured under stringent quality and compliance standards

This medication is widely used in the management of acid-related gastrointestinal disorders. It helps reduce acid production and promotes healing of the gastrointestinal lining.

  • Gastroesophageal reflux disease (GERD)
  • Acid reflux and persistent heartburn
  • Gastric and duodenal ulcers
  • Zollinger–Ellison syndrome
  • Prevention of NSAID-induced gastric ulcers

The delayed-release formulation enhances drug stability and therapeutic effectiveness by ensuring proper site-specific release. It supports improved patient compliance and consistent outcomes.

  • Ensures targeted release beyond the stomach
  • Provides long-lasting acid suppression
  • Minimizes degradation of active ingredient
  • Improves treatment effectiveness and consistency
  • Convenient dosing for better adherence
  • Stable formulation suitable for large-scale production and global supply

whatsapp-app